The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Acinetobacter baumannii Antibiotic Resistance Mechanisms
Open accessAbstract
Acinetobacter baumannii is a Gram-negative ESKAPE microorganism that poses a threat to public health by causing severe and invasive (mostly nosocomial) infections linked with high mortality rates. During the last years, this pathogen displayed multidrug resistance (MDR), mainly due to extensive antibiotic abuse and poor stewardship. MDR isolates are associated with medical history of long hospitalization stays, presence of catheters, and mechanical ventilation, while immunocompromised and severely ill hosts predispose to invasive infections. Next-generation sequencing techniques have revolutionized diagnosis of severe A. baumannii infections, contributing to timely diagnosis and personalized therapeutic regimens according to the identification of the respective resistance genes. The aim of this review is to describe in detail all current knowledge on the genetic background of A. baumannii resistance mechanisms in humans as regards beta-lactams (penicillins, cephalosporins, carbapenems, monobactams, and beta-lactamase inhibitors), aminoglycosides, tetracyclines, fluoroquinolones, macrolides, lincosamides, streptogramin antibiotics, polymyxins, and others (amphenicols, oxazolidinones, rifamycins, fosfomycin, diaminopyrimidines, sulfonamides, glycopeptide, and lipopeptide antibiotics). Mechanisms of antimicrobial resistance refer mainly to regulation of antibiotic transportation through bacterial membranes, alteration of the antibiotic target site, and enzymatic modifications resulting in antibiotic neutralization. Virulence factors that may affect antibiotic susceptibility profiles and confer drug resistance are also being discussed. Reports from cases of A. baumannii coinfection with SARS-CoV-2 during the COVID-19 pandemic in terms of resistance profiles and MDR genes have been investigated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis
Sauvage, E., Kerff, F., Terrak, M., Ayala, J. A., & Charlier, P. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00105.x · Cited by 1,317
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,139
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
Tooke, C. L., Hinchliffe, P., Bragginton, E. C., Colenso, C. K., Hirvonen, V. H. A., Takebayashi, Y., & Spencer, J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.002 · Cited by 1,016
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K., & Hooper, D. C. (2006) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,013
The worldwide emergence of plasmid-mediated quinolone resistance
Robicsek, A., Jacoby, G. A., & Hooper, D. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70599-0 · Cited by 966
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Nordmann, P., & Poirel, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz824 · Cited by 721
Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans
He, T., Wang, R., Liu, D., Walsh, T. R., Zhang, R., Lv, Y., Ke, Y., Ji, Q., Wei, R., Liu, Z., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0445-2 · Cited by 705
Penicillin-binding proteins and β-lactam resistance
Zapun, A., Contreras-Martel, C., & Vernet, T. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00095.x · Cited by 687
Diversity, Epidemiology, and Genetics of Class D β-Lactamases
Poirel, L., Naas, T., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-08 · Cited by 632
Ayoub Moubareck, C., & Hammoudi Halat, D. (2020) · Antibiotics · doi:10.3390/antibiotics9030119 · Cited by 627
Metallo-β-lactamases: a last frontier for β-lactams?
Cornaglia, G., Giamarellou, H., & Rossolini, G. M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70056-1 · Cited by 613
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
Garneau-Tsodikova, S., & Labby, K. J. (2016) · MedChemComm · doi:10.1039/c5md00344j · Cited by 576
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
Efflux-Mediated Antibiotic Resistance in Acinetobacter spp
Coyne, S., Courvalin, P., & Périchon, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01388-10 · Cited by 505
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
Vila, J., Martí, S., & Sánchez-Céspedes, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl509 · Cited by 436
Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU
Sharifipour, E., Shams, S., Esmkhani, M., Khodadadi, J., Fotouhi-Ardakani, R., Koohpaei, A., Doosti, Z., & EJ Golzari, S. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05374-z · Cited by 417
Marchand, I., Damier-Piolle, L., Courvalin, P., & Lambert, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3298-3304.2004 · Cited by 407
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
Ripa, M., Galli, L., Poli, A., Oltolini, C., Spagnuolo, V., Mastrangelo, A., Muccini, C., Monti, G., De Luca, G., Landoni, G., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.10.021 · Cited by 363
Damier-Piolle, L., Magnet, S., Brémont, S., Lambert, T., & Courvalin, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00732-07 · Cited by 357
Molecular understanding of aminoglycoside action and resistance
Jana, S., & Deb, J. K. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0279-0 · Cited by 336
The emerging problem of linezolid-resistant Staphylococcus
Gu, B., Kelesidis, T., Tsiodras, S., Hindler, J., & Humphries, R. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks354 · Cited by 332
Contou, D., Claudinon, A., Pajot, O., Micaëlo, M., Longuet Flandre, P., Dubert, M., Cally, R., Logre, E., Fraissé, M., Mentec, H., et al. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00736-x · Cited by 325
Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options
Murray, G., Peleg, A., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398388 · Cited by 316
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
Vázquez-López, R., Solano-Gálvez, S. G., Juárez Vignon-Whaley, J. J., Abello Vaamonde, J. A., Padró Alonzo, L. A., Rivera Reséndiz, A., Muleiro Álvarez, M., Vega López, E. N., Franyuti-Kelly, G., Álvarez-Hernández, D. A., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9040205 · Cited by 296
Mussi, M. A., Limansky, A. S., & Viale, A. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1432-1440.2005 · Cited by 276
oqxAB Encoding a Multidrug Efflux Pump in Human Clinical Isolates of Enterobacteriaceae
Kim, H. B., Wang, M., Park, C. H., Kim, E.-C., Jacoby, G. A., & Hooper, D. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01574-08 · Cited by 271
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
Héritier, C., Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01320.x · Cited by 266
Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation
Yang, C.-H., Su, P.-W., Moi, S.-H., & Chuang, L.-Y. (2019) · Molecules · doi:10.3390/molecules24101849 · Cited by 259
Diversity of Tetracycline Resistance Genes in Bacteria from Chilean Salmon Farms
Miranda, C. D., Kehrenberg, C., Ulep, C., Schwarz, S., & Roberts, M. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.883-888.2003 · Cited by 246
Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment
Piperaki, E.-T., Tzouvelekis, L. S., Miriagou, V., & Daikos, G. L. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.014 · Cited by 240
Poirel, L., Menuteau, O., Agoli, N., Cattoen, C., & Nordmann, P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3542-3547.2003 · Cited by 235
Fernandez-Cuenca, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg097 · Cited by 229
Mechanisms of Polymyxin Resistance
Moffatt, J. H., Harper, M., & Boyce, J. D. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-16373-0_5 · Cited by 220
Structural basis for TetM-mediated tetracycline resistance
Dönhöfer, A., Franckenberg, S., Wickles, S., Berninghausen, O., Beckmann, R., & Wilson, D. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208037109 · Cited by 217
Perez, S., Innes, G. K., Walters, M. S., Mehr, J., Arias, J., Greeley, R., & Chew, D. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6948e1 · Cited by 216
Role of OmpA in the Multidrug Resistance Phenotype of Acinetobacter baumannii
Smani, Y., Fàbrega, A., Roca, I., Sánchez-Encinales, V., Vilà, J., & Pachón, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02101-13 · Cited by 212
Yoon, E.-J., Nait Chabane, Y., Goussard, S., Snesrud, E., Courvalin, P., Dé, E., & Grillot-Courvalin, C. (2015) · mBio · doi:10.1128/mbio.00309-15 · Cited by 210
rRNA Binding Sites and the Molecular Mechanism of Action of the Tetracyclines
Chukwudi, C. U. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00594-16 · Cited by 204
Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene
Ito, R., Mustapha, M. M., Tomich, A. D., Callaghan, J. D., McElheny, C. L., Mettus, R. T., Shanks, R. M. Q., Sluis-Cremer, N., & Doi, Y. (2017) · mBio · doi:10.1128/mbio.00749-17 · Cited by 204
Rumbo, C., Gato, E., López, M., Ruiz de Alegría, C., Fernández-Cuenca, F., Martínez-Martínez, L., Vila, J., Pachón, J., Cisneros, J. M., Rodríguez-Baño, J., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00730-13 · Cited by 193
Mohd Sazlly Lim, S., Zainal Abidin, A., Liew, S. M., Roberts, J. A., & Sime, F. B. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.09.012 · Cited by 193
Vrancianu, C. O., Gheorghe, I., Czobor, I. B., & Chifiriuc, M. C. (2020) · Microorganisms · doi:10.3390/microorganisms8060935 · Cited by 188
Karakonstantis, S., Kritsotakis, E. I., & Gikas, A. (2020) · Infection · doi:10.1007/s15010-020-01520-6 · Cited by 182
Structural basis for Acinetobacter baumannii biofilm formation
Pakharukova, N., Tuittila, M., Paavilainen, S., Malmi, H., Parilova, O., Teneberg, S., Knight, S. D., & Zavialov, A. V. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800961115 · Cited by 180
Wang, L., Liu, D., Lv, Y., Cui, L., Li, Y., Li, T., Song, H., Hao, Y., Shen, J., Wang, Y., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01326-19 · Cited by 174
Richmond, G. E., Evans, L. P., Anderson, M. J., Wand, M. E., Bonney, L. C., Ivens, A., Chua, K. L., Webber, M. A., Sutton, J. M., Peterson, M. L., et al. (2016) · mBio · doi:10.1128/mbio.00430-16 · Cited by 161
Wu, N., Dai, J., Guo, M., Li, J., Zhou, X., Li, F., Gao, Y., Qu, H., Lu, H., Jin, J., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1902754 · Cited by 159
OmpA Is the Principal Nonspecific Slow Porin of Acinetobacter baumannii
Sugawara, E., & Nikaido, H. (2012) · Journal of Bacteriology · doi:10.1128/jb.00435-12 · Cited by 157
The bacterial cell wall as a source of antibacterial targets
Green, D. W. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.1.1 · Cited by 156
Managing Acinetobacter baumannii infections
Garnacho‐Montero, J., & Timsit, J. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000518 · Cited by 156
Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii
Nasr, P. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.09.021 · Cited by 149
Turton, J. F., Kaufmann, M. E., Glover, J., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3074-3082.2005 · Cited by 146
Srinivasan, V. B., Rajamohan, G., & Gebreyes, W. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00748-09 · Cited by 145
Hameed, F., Khan, M. A., Muhammad, H., Sarwar, T., Bilal, H., & Rehman, T. U. (2019) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0237-2019 · Cited by 135
Epidemiology of common resistant bacterial pathogens in the countries of the Arab League
Moghnieh, R., Kanafani, Z. A., Tabaja, H., Sharara, S. L., Awad, L. S., & Kanj, S. S. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30414-6 · Cited by 134
Siroy, A., Molle, V., Guillier, C., Vallenet, D., Pestel‐Caron, M., Cozzone, A. J., Jouenne, T., & Dé, E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4876-4883.2005 · Cited by 132
Nhu, N. T. K., Riordan, D. W., Nhu, T. D. H., et al. (2016) · Scientific Reports · doi:10.1038/srep28291 · Cited by 123
Fitzpatrick, M. A., Ozer, E. A., & Hauser, A. R. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01818-15 · Cited by 122
Substrate Specificities and Efflux Efficiencies of RND Efflux Pumps of Acinetobacter baumannii
Leus, I. V., Weeks, J. W., Bonifay, V., Smith, L., Richardson, S., & Zgurskaya, H. I. (2018) · Journal of Bacteriology · doi:10.1128/jb.00049-18 · Cited by 119
Rajamohan, G., Srinivasan, V. B., & Gebreyes, W. A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq195 · Cited by 118
Ramadan, H. K., Mahmoud, M. A., Aburahma, M. Z., Elkhawaga, A. A., El‐Mokhtar, M. A., Sayed, I. M., Hosni, A. M., Hassany, S. M., & Medhat, M. A. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s272605 · Cited by 116
Luke, N. R., Sauberan, S. L., Russo, T. A., Beanan, J. M., Olson, R., Loehfelm, T. W., Cox, A. D., St. Michael, F., Vinogradov, E. V., & Campagnari, A. A. (2010) · Infection and Immunity · doi:10.1128/iai.00016-10 · Cited by 114
Sharma, A., Sharma, R., Bhattacharyya, T., Bhando, T., & Pathania, R. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw382 · Cited by 113
Liu, J., Deng, Y., Zeng, Z., Gao, J.-H., Chen, L., Arakawa, Y., & Zhang-liu, C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01686-07 · Cited by 112
Levy-Blitchtein, S., Roca, I., Plasencia-Rebata, S., Taboada, W. V., Velásquez-Pomar, J., Muñoz, L., Moreno-Morales, J., Pons, M. J., del Valle-Mendoza, J., & Vilà, J. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0127-9 · Cited by 111
A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain
Martins, N., Snesrud, E. C., Xavier, D. E., Cacci, L. C., Iavarone, A. T., McGann, P., Riley, L. W., & Moreira, B. M. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz413 · Cited by 111
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases
Walther‐Rasmussen, J., & Høiby, N. (2004) · Canadian Journal of Microbiology · doi:10.1139/w03-111 · Cited by 110
Crystal structure of tripartite-type ABC transporter MacB from Acinetobacter baumannii
Okada, U., Yamashita, E., Neuberger, A., Morimoto, M., van Veen, H. W., & Murakami, S. (2017) · Nature Communications · doi:10.1038/s41467-017-01399-2 · Cited by 110
Mussi, M. A., Relling, V. M., Limansky, A. S., & Viale, A. M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.10.063 · Cited by 107
Rolain, J., Diene, S. M., Kempf, M., Gimenez, G., Robert, C., & Raoult, D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01314-12 · Cited by 104
Protein determinants of dissemination and host specificity of metallo-β-lactamases
López, C., Ayala, J. A., Bonomo, R. A., González, L. J., & Vila, A. J. (2019) · Nature Communications · doi:10.1038/s41467-019-11615-w · Cited by 102
Bacterial and fungal co-infections among COVID-19 patients in intensive care unit
Yang, S., Hua, M., Liu, X., Du, C., Pu, L., Xiang, P., Wang, L., & Liu, J. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104806 · Cited by 99
Antunes, N., & Fisher, J. F. (2014) · Antibiotics · doi:10.3390/antibiotics3030398 · Cited by 98
Acinetobacter baumannii OmpA Is a Selective Antibiotic Permeant Porin
Iyer, R., Moussa, S. H., Durand-Réville, T. F., Tommasi, R., & Miller, A. A. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00168 · Cited by 98
Yoon, E.-J., Balloy, V., Fiette, L., Chignard, M., Courvalin, P. M., & Grillot‐Courvalin, C. (2016) · mBio · doi:10.1128/mbio.00697-16 · Cited by 94
Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection
Hawkey, J., Ascher, D. B., Judd, L. M., Wick, R. R., Kostoulias, X., Cleland, H. J., Spelman, D. W., Padiglione, A. A., Peleg, A. Y., & Holt, K. E. (2018) · Microbial Genomics · doi:10.1099/mgen.0.000165 · Cited by 93
Xiong, X., Bromley, E. H. C., Oelschlaeger, P., Woolfson, D. N., & SPENCER, J. M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1296 · Cited by 92
Siroy, A., Cosette, P., Seyer, D., Guillier, C., Vallenet, D., DORSSELAER, A. V., Boyer-Mariotte, S., Jouenne, T., & Dé, E. (2006) · Journal of Proteome Research · doi:10.1021/pr060372s · Cited by 91
Catel‐Ferreira, M., Coadou, G., Molle, V., Mugnier, P. D., Nordmann, P., Siroy, A., Jouenne, T., & Dé, E. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr267 · Cited by 87
Ewers, C., Klotz, P., Leidner, U., Stamm, I., Prenger‐Berninghoff, E., Göttig, S., Semmler, T., & Scheufen, S. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.09.033 · Cited by 87
Genetic Determinants of Intrinsic Colistin Tolerance in Acinetobacter baumannii
Hood, M. I., Becker, K. W., Roux, C. M., Dunman, P. M., & Skaar, E. P. (2012) · Infection and Immunity · doi:10.1128/iai.00704-12 · Cited by 85
Lopes, B. S., & Amyes, S. G. B. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.044156-0 · Cited by 85
Gerson, S., Betts, J. W., Lucaßen, K., Nodari, C. S., Wille, J., Josten, M., Göttig, S., Nowak, J., Stefanik, D., Roca, I., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01586-18 · Cited by 84
Chatterjee, S., Datta, S., Roy, S., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01126 · Cited by 83
Silva, P. M. D., & Kumar, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00049 · Cited by 79
Hou, P., Chen, X. Y., Yan, G. F., Wang, Y. P., & Ying, C. M. (2012) · Chemotherapy · doi:10.1159/000335599 · Cited by 74
Structural Insights into Outer Membrane Permeability of Acinetobacter baumannii
Zahn, M., Bhamidimarri, S. P., Baslé, A., Winterhalter, M., & van den Berg, B. (2016) · Structure · doi:10.1016/j.str.2015.12.009 · Cited by 74
Karruli, A., Boccia, F., Gagliardi, M., Patauner, F., Ursi, M. P., Sommese, P., Rosa, R. C. D., Murino, P., Ruocco, G., Corcione, A., et al. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0489 · Cited by 74
Luna, B. M., Trebosc, V., Lee, B., Bakowski, M. A., Ulhaq, A., Yan, J., Lu, P., Cheng, J., Nielsen, T. B., Lim, J., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0737-6 · Cited by 71
Mosaic tetracycline resistance genes encoding ribosomal protection proteins
Warburton, P., Amodeo, N., & Roberts, A. P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw304 · Cited by 69
Sekyere, J. O., & Reta, M. A. (2020) · mSystems · doi:10.1128/msystems.00897-20 · Cited by 69
Drug resistance and virulence traits of Acinetobacter baumannii from Turkey and chicken raw meat
Kanaan, M. H. G., Al-Shadeedi, S. M. J., Al-Massody, A. J., & Ghasemian, A. (2020) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2020.101451 · Cited by 67
Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19
Durán-Manuel, E. M., Cruz-Cruz, C., Ibáñez-Cervantes, G., Bravata-Alcántara, J. C., Sosa-Hernández, Ó., Delgado–Balbuena, L., León-García, G., Cortés-Ortíz, I. A., Cureño-Díaz, M. A., Castro‐Escarpulli, G., et al. (2021) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.13545 · Cited by 63
Deciphering the Function of the Outer Membrane Protein OprD Homologue of Acinetobacter baumannii
Catel‐Ferreira, M., Nehmé, R., Molle, V., Aranda, J., Bouffartigues, E., Chevalier, S., Bou, G., Jouenne, T., & Dé, E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06022-11 · Cited by 61
Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii
Ribera, A., Ruiz, J., & Vilà, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2310-2312.2003 · Cited by 61
Mussi, M. A., Limansky, A. S., Relling, V. M., Ravasi, P., Arakaki, A. K., Actis, L. A., & Viale, A. M. (2011) · Journal of Bacteriology · doi:10.1128/jb.01533-10 · Cited by 61
Girija, A. S. S., Jayaseelan, V. P., & Arumugam, P. (2018) · British Journal of Biomedical Science · doi:10.1080/09674845.2018.1492207 · Cited by 60
Lari, A. R., Ardebili, A., & Hashemi, A. (2018) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_644_16 · Cited by 58
Yun, S., Choi, C.-W., Kwon, S., Park, G. W., Cho, K., Kwon, K., Kim, J. Y., Yoo, J. S., Lee, J. C., Choi, J., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr101012s · Cited by 57
New Mutations Involved in Colistin Resistance in Acinetobacter baumannii
Sun, B., Liu, H., Jiang, Y., Shao, L., Yang, S., & Chen, D. (2020) · mSphere · doi:10.1128/msphere.00895-19 · Cited by 57
Huang, L., Sun, L., Xu, G., et al. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.06.008 · Cited by 54
Martinez, T., Martínez, I., Vázquez, G. J., Aquino, E. E., & Robledo, I. E. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000289 · Cited by 53
Hamidian, M., & Hall, R. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt312 · Cited by 52
Sánchez−Osuna, M., Cortés, P., Llagostera, M., Barbé, J., & Erill, I. (2020) · Microbial Genomics · doi:10.1099/mgen.0.000440 · Cited by 52
Xu, A., Zhu, H., Gao, B., Weng, H., Ding, Z., Li, M., Weng, X., & He, G. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-019-4733-5 · Cited by 50
Nebreda-Mayoral, T., Miguel-Gómez, M. A., March-Rosselló, G. A., Puente-Fuertes, L., Cantón-Benito, E., Martínez-García, A. M., Muñoz-Martín, A. B., & Orduña‐Domingo, A. (2020) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2020.11.003 · Cited by 49
Kuo, S., Lee, Y., Lauderdale, T.-L. Y., Huang, W., Chuang, M.-F., Chen, C.-P., Su, S.-C., Lee, K., & Chen, T.-L. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00231 · Cited by 48
Krzyściak, P., Chmielarczyk, A., Pobiega, M., Romaniszyn, D., & Wójkowska‐Mach, J. (2017) · Apmis · doi:10.1111/apm.12739 · Cited by 48
Genetic and Functional Variability of AmpC-Type β-Lactamases from Acinetobacter baumannii
Rodríguez-Martínez, J. M., Poirel, L., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00427-10 · Cited by 44
Wareth, G., Linde, J., Hammer, P., Nguyen, N. H., Nguyen, T. N., Splettstoesser, W. D., Makarewicz, O., Neubauer, H., Sprague, L., & Pletz, M. W. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106127 · Cited by 44
Sonkar, A. K., Shukla, H., Shukla, R., Kalita, J., Pandey, T., & Tripathi, T. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.12.082 · Cited by 42
High-Level Macrolide Resistance Due to the Mega Element [mef(E)/mel] in Streptococcus pneumoniae
Schroeder, M. R., Lohsen, S., Chancey, S. T., & Stephens, D. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00868 · Cited by 42
Amin, M., Navidifar, T., Shooshtari, F. S., & Goodarzi, H. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s196575 · Cited by 41
Yuhan, Y., Ziyun, Y., Yongbo, Z., Li, F., & Qinghua, Z. (2016) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0411-2015 · Cited by 37
Cecchini, T., Yoon, E.-J., Charretier, Y., Bardet, C., Beaulieu, C., Lacoux, X., Docquier, J., Lemoine, J., Courvalin, P. M., Grillot‐Courvalin, C., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000107 · Cited by 35
Ingti, B., Upadhyay, S., Hazarika, M., Khyriem, A. B., Paul, D., Bhattacharya, P., Joshi, S. R., Bora, D., Dhar, D., & Bhattacharjee, A. (2020) · Research in Microbiology · doi:10.1016/j.resmic.2020.01.002 · Cited by 35
Lai, J.-H., Yang, J.-T., Chern, J., Chen, T.-L., Wu, W., Liao, J., Tsai, S., Liang, S., Chou, C., & Wu, S. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.051052 · Cited by 32
Huang, C., Long, Q., Qian, K., Fu, T., Zhang, Z., Liao, P., & Xie, J. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.09.015 · Cited by 32
Lean, S. S., Yeo, C. C., Suhaili, Z., & Thong, K. L. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.10.015 · Cited by 30
Claeys, K. C., Fiorvento, A. D., & Rybak, M. J. (2014) · Infectious Diseases and Therapy · doi:10.1007/s40121-014-0051-9 · Cited by 29
Li, X., Quan, J., Yang, Y. F., Ji, J. S., Liu, L., Fu, Y., Hua, X., Chen, Y., Pi, B., Jiang, Y., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2674-0 · Cited by 29
Traglia, G. M., Chiem, K., Quinn, B., Fernandez, J. S., Montaña, S., Almuzara, M. N., Mussi, M. A., Tolmasky, M. E., Iriarte, A., Centrón, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35377-5 · Cited by 28
Yamada, K., Morinaga, Y., Yanagihara, K., Kaku, N., Harada, Y., Uno, N., Nakamura, S., Imamura, Y., Hasegawa, H., Miyazaki, T., et al. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.05.006 · Cited by 25
D’Souza, R., Pinto, N. A., Phuong, N. L., Higgins, P. G., Vu, T. N., Byun, J., Cho, Y. L., Choi, J. R., & Yong, D. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00559 · Cited by 24
Prevalence of tetracycline resistance genes in Greek seawater habitats
Nikolakopoulou, T. L., Giannoutsou, E. P., Karabatsou, A. A., & Karagouni, A. D. (2008) · The Journal of Microbiology · doi:10.1007/s12275-008-0080-8 · Cited by 23
Zhong, X., Wu, X., Schweppe, D. K., Chavez, J. D., Mathay, M., Eng, J. K., Keller, A., & Bruce, J. E. (2019) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.9b00021 · Cited by 21
The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
Li, L., Hassan, K. A., Tetu, S. G., Naidu, V., Pokhrel, A., Cain, A. K., & Paulsen, I. T. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.565438 · Cited by 20
Moulana, Z., Babazadeh, A., Eslamdost, Z., Shokri, M., & Ebrahimpour, S. (2020) · PubMed Central · doi:10.22088/cjim.11.2.171 · Cited by 18
Luna, B. M., Ulhaq, A., Yan, J., Pantapalangkoor, P., Nielsen, T. B., Davies, B. W., Actis, L. A., & Spellberg, B. J. (2017) · mSphere · doi:10.1128/msphere.00140-17 · Cited by 17
Li, P., Huang, Y., Yu, L., Liu, Y., Niu, W., Zou, D., Liu, H., Zheng, J., Yin, X., Yuan, J., et al. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.07.005 · Cited by 16
López-Durán, P. A., Fonseca-Coronado, S., Lozano-Trenado, L. M., Araujo-Betanzos, S., Trujillo, D. A. R., Vaughan, G., & Saldaña-Rivera, E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231829 · Cited by 14
One Outbreak Could Hide Another
Duployez, C., Guern, R. L., Millière, L., Caplan, M., Loïez, C., Ledoux, G., Jaillette, E., Favory, R., Mathieu, D., & Wallet, F. (2020) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2020.705 · Cited by 11
Paul, D., Mallick, S., Das, S., Saha, S., Ghosh, A. K., & Mandal, S. M. (2019) · Infectious Disorders - Drug Targets · doi:10.2174/1871526519666190426153258 · Cited by 10
Hemoglobinopatisi olan bir bebekte biliyer atrezi komplikasyonu olarak kandidemi
Kyriakidis, I. (2019) · Türk Pediatri Arşivi · doi:10.14744/turkpediatriars.2019.67674 · Cited by 6
Self-citation
Cited by
Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now?
Kariuki, S., Kering, K., Wairimu, C., Onsare, R., & Mbae, C. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s342753 · Cited by 245
Metadata
- Authors
- Kyriakidis, I., Vasileiou, E., Pana, Z. D., & Tragiannidis, A.
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2021-03-19
- Volume
- 10
- Issue
- 3
- Pages
- 373
- ISSN
- 2076-0817 (ISSN-L)
- OpenAlex
- W3136632618
- Cited by
- 678
- References
- 147
- FWCI
- 26.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.